当前位置:首页 - 行情中心 - 睿昂基因(688217) - 财务分析 - 现金流量表

睿昂基因

(688217)

  

流通市值:16.61亿  总市值:16.61亿
流通股本:5585.59万   总股本:5585.59万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金41,798,422.01201,241,619.37156,046,434.85108,514,219.59
  收到的税费返还-1,444,600.07--
  收到其他与经营活动有关的现金3,071,581.0713,552,737.9311,170,851.387,421,242.31
  经营活动现金流入小计44,870,003.08216,238,957.37167,217,286.23115,935,461.9
  购买商品、接受劳务支付的现金8,703,862.5444,300,968.2831,790,293.1925,623,704.4
  支付给职工以及为职工支付的现金18,868,924.0880,040,299.9360,546,569.743,741,515.81
  支付的各项税费5,510,227.5821,383,441.7317,337,356.8911,568,977.89
  支付其他与经营活动有关的现金10,066,491.9524,967,442.7930,681,834.5117,515,378.89
  经营活动现金流出的平衡项目000.010.01
  经营活动现金流出小计43,149,506.15170,692,152.73140,356,054.398,449,577
  经营活动产生的现金流量净额1,720,496.9345,546,804.6426,861,231.9317,485,884.9
二、投资活动产生的现金流量:
  收回投资收到的现金108,700,000208,385,000152,385,000142,385,000
  取得投资收益收到的现金584,573.742,371,403.581,709,855.461,560,616.96
  处置固定资产、无形资产和其他长期资产收回的现金净额-265,486.73--
  投资活动现金流入小计109,284,573.74211,021,890.31154,094,855.46143,945,616.96
  购建固定资产、无形资产和其他长期资产支付的现金137,846.1826,761,268.925,858,952.9124,479,540.12
  投资支付的现金91,000,000231,000,000158,400,000124,700,000
  投资活动现金流出小计91,137,846.18257,761,268.9184,258,952.91149,179,540.12
  投资活动产生的现金流量净额18,146,727.56-46,739,378.59-30,164,097.45-5,233,923.16
三、筹资活动产生的现金流量:
  偿还债务支付的现金-16,250,00016,250,00016,250,000
  分配股利、利润或偿付利息支付的现金-9,503,651.13111,168.59111,168.59
  支付其他与筹资活动有关的现金746,988.83,183,216.921,838,1631,658,085.47
  筹资活动现金流出小计746,988.828,936,868.0518,199,331.5918,019,254.06
  筹资活动产生的现金流量净额-746,988.8-28,936,868.05-18,199,331.59-18,019,254.06
四、汇率变动对现金及现金等价物的影响-805,298.35-1,010,275.62-459,761.34-145,441.56
五、现金及现金等价物净增加额18,314,937.34-31,139,717.62-21,961,958.45-5,912,733.88
  加:期初现金及现金等价物余额104,403,268.37135,542,985.99135,542,985.99135,542,985.99
  期末现金及现金等价物余额122,718,205.71104,403,268.37113,581,027.54129,630,252.11
补充资料:
  净利润--60,420,101.66--1,120,256
  资产减值准备-29,240,817.07-258,053.3
  固定资产和投资性房地产折旧-27,670,811.3-14,565,055.41
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,670,811.3-14,565,055.41
  无形资产摊销-9,614,925.62-4,843,148.64
  长期待摊费用摊销-685,219.12-350,638.21
  处置固定资产、无形资产和其他长期资产的损失--128,618.81--47,904.93
  固定资产报废损失-657,627.6-29,731.37
  公允价值变动损失--1,245,915.61-479,941.91
  财务费用-1,207,759.2-298,082.68
  投资损失--2,371,403.58--1,560,616.96
  递延所得税-5,617,693.23--3,567,541.21
  其中:递延所得税资产减少-7,115,725.18--2,582,393.07
    递延所得税负债增加--1,498,031.95--985,148.14
  存货的减少-6,975,401.59-5,847,880.29
  经营性应收项目的减少-12,926,332.23--5,767,511.61
  经营性应付项目的增加--780,854.54--2,674,367.13
  其他--617,112.5--
  不涉及现金收支的投资和筹资活动金额其他项目-0--
  现金的期末余额-104,403,268.37-129,630,252.11
  减:现金的期初余额-135,542,985.99-135,542,985.99
  现金及现金等价物的净增加额--31,139,717.62--5,912,733.88
公告日期2026-04-282026-04-112025-10-292025-08-29
审计意见(境内)标准无保留意见
TOP↑